a company called Affirm had good news about their money and people are happy about it. So, the price of their shares went up by around 18%. This is like if you had 100 toy cars and you got 18 more, you would be very happy, right? So, some other companies also got good news and their prices went up too. And some other companies had bad news and their prices went down. Read from source...

in the article, the author gives prominence to Affirm's strong fourth-quarter earnings and upbeat first-quarter guidance as the reason for its shares trading higher. However, the author failed to provide a comprehensive explanation as to why other stocks mentioned in the pre-market movers list are gaining or losing traction. Furthermore, the negative sentiments towards Big Lots and the possible bankruptcy filing were not justified, as there might be other factors influencing the company's decline. There is also a lack of objectivity as the author did not give an equal proportion of negative and positive sentiments towards each mentioned company. Overall, the article lacks balanced analysis and suffers from superficial insights.

1. Affirm Holdings, Inc. (AFRM) - The stock rose around 18% in pre-market trading due to strong Q4 earnings and upbeat Q1 guidance. However, despite beating analyst estimates for both earnings and revenue, the company still reported a quarterly loss of 14 cents per share. There is an overall positive sentiment towards the stock, but potential investors should consider the company's loss and the possibility of continued losses in the future.

2. BioCardia, Inc. (BCDA) - FDA cleared the company's Morph DNA Steerable Introducer product family, leading to a 109.5% gain in pre-market trading. This could be a lucrative opportunity for investors interested in the medical device industry. However, the stock is relatively unknown and may have limited liquidity, increasing the risk for investors.

3. Autozi Internet Technology (Global) Ltd. (AZI) - The stock rose 101.5% in pre-market trading after the company announced the pricing of its initial public offering (IPO). This shows strong investor interest and could indicate potential growth, although it is always important to consider the company's financials and market conditions before investing.

4. Theriva Biologics, Inc. (TOVX) - The company announced that it received a US patent application notice of allowance for treating C. Difficile disease and other antibiotic-induced GI tract adverse effects, leading to a 24.3% gain in pre-market trading. This is a promising development for the company and could make it an attractive investment opportunity for those interested in the biotech sector. However, the stock is relatively unknown and may have limited liquidity, increasing the risk for investors.

5. BranchOut Food Inc. (BOF) - The stock gained 21.2% in pre-market trading following a year-over-year increase in H1 revenue results. This indicates potential growth and could make the stock attractive for those interested in the food industry. However, investors should consider the company's overall financials and market conditions before investing.

6. Nutanix, Inc. (NTNX) - The company reported better-than-expected Q4 financial results and issued FY25 revenue guidance above estimates, leading to a 16.5% gain in pre-market trading. This suggests strong investor interest and potential growth, although investors should still carefully consider the company's overall financials and market conditions before investing.

7. Quantum BioPharma Ltd. (QNTM) - The stock gained 13% in pre-market trading. While there is no specific news or development driving this increase, the overall positive sentiment towards the stock could indicate potential growth. However, investors should consider the company's financials and market conditions before making any investment decisions.

8. Five Below, Inc. (FIVE) - The stock rose 7% in pre-market trading following better-than-expected quarterly revenue results. This indicates potential growth and could make the stock attractive for